Ghent
Belgium
46
2013-07-11
31
2014-04-01
These are the the leading inventors for applications assigned to Innogenetics N.V.:
Innogenetics N.V. based in Ghent, BE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
DETECTION, IDENTIFICATION AND DIFFERENTIATION OF SERRATIA SPECIES USING THE SPACER REGION
#2 | 2013-07-04DETECTION, IDENTIFICATION AND DIFFERENTIATION OF PROTEUS SPECIES USING THE SPACER REGION
#3 | 2013-02-14 ✅ Patent 8,686,126 granted on 2014-04-01HBV drug resistance methods
#4 | 2010-05-13 ✅ Patent 8,101,351 granted on 2012-01-24Process for typing of HCV isolates
#5 | 2010-04-22 ✅ Patent 8,426,129 granted on 2013-04-23Method for typing HLA alleles
#6 | 2009-08-06 ✅ Patent 8,835,106 granted on 2014-09-16Method for typing and detecting HBV
#7 | 2009-07-30DETECTION, IDENTIFICATION AND DIFFERENTIATION OF SERRATIA SPECIES USING THE SPACER REGION
#8 | 2009-06-11IDENTIFICATION OF MICROORGANISMS CAUSING ACUTE RESPIRATORY TRACT INFECTIONS (ARI)
#9 | 2009-04-16DETECTION, IDENTIFICATION AND DIFFERENTIATION OF PROTEUS SPECIES USING THE SPACER REGION
#10 | 2009-01-15DETECTION, IDENTIFICATION AND DIFFERENTIATION OF EUBACTERIAL TAXA USING A HYBRIDIZATION ASSAY
#11 | 2008-11-06HCV E1 COMPRISING SPECIFIC DISULFIDE BRIDGES
#12 | 2008-08-21 ✅ Patent 8,945,850 granted on 2015-02-03Detection, identification and differentiation of using a hybridization assay
#13 | 2008-06-17 ✅ Patent 7,387,879 granted on 2008-06-17Diagnosis of tauopathies
#14 | 2008-06-12PURIFIED HEPATITIS C VIRUS ENVELOPE PROTEINS FOR DIAGNOSTIC AND THERAPEUTIC USE
#15 | 2008-01-01 ✅ Patent 7,314,925 granted on 2008-01-01Constructs and methods for expression of recombinant HCV envelope proteins
#16 | 2007-12-25 ✅ Patent 7,313,357 granted on 2007-12-25Method for typing and detecting HBV
#17 | 2007-08-21 ✅ Patent 7,258,977 granted on 2007-08-21Process for typing of HCV isolates
#18 | 2007-08-21 ✅ Patent 7,258,861 granted on 2007-08-21TNF-derived peptides for use in treating oedema
#19 | 2007-08-07 ✅ Patent 7,252,936 granted on 2007-08-07Method for the detection of the antibiotic resistance spectrum of Mycobacterium species
#20 | 2007-07-03 ✅ Patent 7,238,356 granted on 2007-07-03Core-glycosylated HCV envelope proteins
#21 | 2007-06-07Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
#22 | 2007-03-27 ✅ Patent 7,196,183 granted on 2007-03-27Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
#23 | 2007-03-01HCV COMBINATION THERAPY
#24 | 2006-12-07Particles of HCV envelope proteins: use for vaccination
#25 | 2006-10-31 ✅ Patent 7,129,337 granted on 2006-10-31Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
#26 | 2006-10-26Method for the detection of pathogenic gram positive bacteria from the genera staphylococcus, enterococcus and streptococcus
#27 | 2006-10-19 ✅ Patent 7,422,848 granted on 2008-09-09Hepatitis-B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
#28 | 2006-09-19 ✅ Patent 7,108,855 granted on 2006-09-19Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
#29 | 2006-09-05 ✅ Patent 7,101,561 granted on 2006-09-05Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
#30 | 2006-07-27 ✅ Patent 8,278,432 granted on 2012-10-02HBV drug resistance methods
#31 | 2006-05-23 ✅ Patent 7,048,930 granted on 2006-05-23Expression of core-glycosylated HCV envelope proteins in yeast
#32 | 2006-05-11Detection, identification and differentiation of Serratia species using the spacer region
#33 | 2006-05-04Peptides for inducing a CTL and/or HTL response to hepatitis C virus
#34 | 2006-04-11 ✅ Patent 7,026,457 granted on 2006-04-11Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
#35 | 2006-02-23 ✅ Patent 7,264,826 granted on 2007-09-04Pharmaceutical compositions of cell lysate and processes for the production and use thereof
#36 | 2006-02-16 ✅ Patent 7,413,741 granted on 2008-08-19HCV E1 comprising specific disulfide bridges
#37 | 2005-12-13 ✅ Patent 6,974,864 granted on 2005-12-13Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
#38 | 2005-07-28 ✅ Patent 7,741,461 granted on 2010-06-22Nucleic acid probes and methods for detecting clinically important fungal pathogens
#39 | 2005-06-30 ✅ Patent 7,390,623 granted on 2008-06-24Detection and identification of and epidermidis using the 16S-23S rRNA spacer
#40 | 2005-05-10 ✅ Patent 6,891,026 granted on 2005-05-10Process for typing of HCV isolates
#41 | 2005-05-10 ✅ Patent 6,890,737 granted on 2005-05-10Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
#42 | 2005-05-03 ✅ Patent 6,887,985 granted on 2005-05-03Process for typing of HCV isolates
#43 | 2005-03-29 ✅ Patent 6,872,520 granted on 2005-03-29Synthetic antigens for the detection of antibodies to hepatitis C virus
#44 | 2005-02-22 ✅ Patent 6,858,387 granted on 2005-02-22Nucleic acid probes and methods for detecting clinically important fungal pathogens
#45 | 2005-01-20Modified HCV NS5
#46 | 2005-01-11 ✅ Patent 6,841,353 granted on 2005-01-11Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue
9401 ⎘